Literature DB >> 1540483

Endothelin-1 induces a histamine-dependent flare in vivo, but does not activate human skin mast cells in vitro.

S D Brain1, G Thomas, D C Crossman, R Fuller, M K Church.   

Abstract

The role of the mast cell in endothelin-1 induced flare has been investigated by in vivo and in vitro experiments. The intradermal injection of endothelin-1 (10 pmol) into human skin induced a pallor with surrounding axon-reflex flare which is similar to the flare response to histamine (1 nmol). At these doses, chosen to give identical flare areas, blood flow was increased in the area of the endothelin-induced flare over a longer period. A systemic H1-receptor antagonist significantly inhibited the area of both flares, although blood flow in the remaining portion of the endothelin-induced flare remained raised. Endothelin-1 at concentrations up to 3 x 10(-5) M failed to release histamine from human dispersed skin mast cells. We suggest from these results that a major component of endothelin-1 induced flare results from mast cell activation that is secondary to direct stimulation of sensory nerves by the peptide.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1540483      PMCID: PMC1381210          DOI: 10.1111/j.1365-2125.1992.tb04011.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Cutaneous blood flow responses in the forearms of Raynaud's patients induced by local cooling and intradermal injections of CGRP and histamine.

Authors:  S D Brain; R G Petty; J D Lewis; T J Williams
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

2.  Cellular signaling by peptides of the endothelin gene family.

Authors:  M S Simonson; M J Dunn
Journal:  FASEB J       Date:  1990-09       Impact factor: 5.191

3.  Endothelin induces potent microvascular constriction.

Authors:  S D Brain; J R Tippins; T J Williams
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

4.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

5.  Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells.

Authors:  M A Lowman; R C Benyon; M K Church
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

6.  Endothelin-1: demonstration of potent effects on the microcirculation of humans and other species.

Authors:  S D Brain; D C Crossman; T L Buckley; T J Williams
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

7.  Potent vasoactive properties of endothelin 1 in human skin.

Authors:  D C Crossman; S D Brain; R W Fuller
Journal:  J Appl Physiol (1985)       Date:  1991-01

8.  Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man.

Authors:  C B Archer; D M MacDonald; J Morley; C P Page; W Paul; S Sanjar
Journal:  Br J Pharmacol       Date:  1985-05       Impact factor: 8.739

9.  Human skin mast cells: their dispersion, purification, and secretory characterization.

Authors:  R C Benyon; M A Lowman; M K Church
Journal:  J Immunol       Date:  1987-02-01       Impact factor: 5.422

10.  Calcitonin gene-related peptide is a potent vasodilator.

Authors:  S D Brain; T J Williams; J R Tippins; H R Morris; I MacIntyre
Journal:  Nature       Date:  1985 Jan 3-9       Impact factor: 49.962

View more
  9 in total

1.  Intradermal administration of endothelin-1 attenuates endothelium-dependent and -independent cutaneous vasodilation via Rho kinase in young adults.

Authors:  Naoto Fujii; Tatsuro Amano; Lyra Halili; Jeffrey C Louie; Sarah Y Zhang; Brendan D McNeely; Glen P Kenny
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-23       Impact factor: 3.619

Review 2.  Endothelin in cardiovascular control: the role of endothelin antagonists.

Authors:  R R Wenzel; P Czyborra; T Lüscher; T Philipp
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

3.  Endothelin-1 induces vasodilation in human skin by nociceptor fibres and release of nitric oxide.

Authors:  R R Wenzel; S Zbinden; G Noll; B Meier; T F Lüscher
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

4.  Effects of endothelin receptor antagonists on bradykinin-induced increases in macromolecular efflux.

Authors:  W G Mayhan; I Rubinstein
Journal:  Inflammation       Date:  1994-12       Impact factor: 4.092

5.  Endothelin-1 modulates methacholine-induced cutaneous vasodilatation but not sweating in young human skin.

Authors:  Lyra Halili; Maya Sarah Singh; Naoto Fujii; Lacy M Alexander; Glen P Kenny
Journal:  J Physiol       Date:  2016-03-11       Impact factor: 5.182

6.  Elevated plasma endothelin levels in systemic sclerosis.

Authors:  T Kadono; K Kikuchi; S Sato; Y Soma; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

7.  Endothelin-1-induced ET(A) receptor-mediated nociception, hyperalgesia and oedema in the mouse hind-paw: modulation by simultaneous ET(B) receptor activation.

Authors:  A P Piovezan; P D'Orléans-Juste; G E Souza; G A Rae
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

8.  Endothelin-1 activates ETA receptors to cause reflex scratching in BALB/c mice.

Authors:  D S McQueen; M A H Noble; S M Bond
Journal:  Br J Pharmacol       Date:  2007-03-12       Impact factor: 8.739

9.  Microinjection of pruritogens in NGF-sensitized human skin.

Authors:  Hans Jürgen Solinski; Roman Rukwied; Martin Schmelz
Journal:  Sci Rep       Date:  2021-11-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.